Report Detail

Request for Sample of this report

Pharma & Healthcare Global Enoxaparin Sodium Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4527648
    • |
  • 12 April, 2023
    • |
  • Global
    • |
  • 128 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.
According to our (Global Info Research) latest study, the global Enoxaparin Sodium market size was valued at USD 3132.6 million in 2022 and is forecast to a readjusted size of USD 5349 million by 2029 with a CAGR of 7.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.
There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.
This report is a detailed and comprehensive analysis for global Enoxaparin Sodium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Enoxaparin Sodium market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Enoxaparin Sodium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Enoxaparin Sodium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Enoxaparin Sodium market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enoxaparin Sodium
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enoxaparin Sodium market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Enoxaparin Sodium market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20 mg/0.2mL
30 mg/0.3mL
40 mg/0.4mL
60 mg/0.6mL
80 mg/0.8mL
100 mg/1mL
120 mg/0.8mL
150 mg/1mL
300mg/3mL
Market segment by Application
Hospital
Clinic
Others
Major players covered
Sanofi
Teva
Techdow (Hepalink)
Fresenius Kabi
Rovi
Amphastar
Nanjing King-friend
Sandoz
Apotex
Hangzhou Jiuyuan Gene Engineering
Cipla
Taj Pharma
Chengdu Baiyu Pharmaceutical
Suzhou Erye Pharmaceutical
Changzhou Qianhong Bio-pharma
Hebei Changshan Biochemical Pharmaceutical
Beijing SL Pharmaceutical
Huadong Medicine
Bharat Serums
INTAS
LUPIN
Troikaa Pharmaceuticals
Aristopharma
Fosun Pharma
SciencePharma
PISA
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enoxaparin Sodium product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enoxaparin Sodium, with price, sales, revenue and global market share of Enoxaparin Sodium from 2018 to 2023.
Chapter 3, the Enoxaparin Sodium competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enoxaparin Sodium breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Enoxaparin Sodium market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enoxaparin Sodium.
Chapter 14 and 15, to describe Enoxaparin Sodium sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Enoxaparin Sodium
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Enoxaparin Sodium Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 20 mg/0.2mL
    • 1.3.3 30 mg/0.3mL
    • 1.3.4 40 mg/0.4mL
    • 1.3.5 60 mg/0.6mL
    • 1.3.6 80 mg/0.8mL
    • 1.3.7 100 mg/1mL
    • 1.3.8 120 mg/0.8mL
    • 1.3.9 150 mg/1mL
    • 1.3.10 300mg/3mL
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Enoxaparin Sodium Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Enoxaparin Sodium Market Size & Forecast
    • 1.5.1 Global Enoxaparin Sodium Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Enoxaparin Sodium Sales Quantity (2018-2029)
    • 1.5.3 Global Enoxaparin Sodium Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Enoxaparin Sodium Product and Services
    • 2.1.4 Sanofi Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Enoxaparin Sodium Product and Services
    • 2.2.4 Teva Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Teva Recent Developments/Updates
  • 2.3 Techdow (Hepalink)
    • 2.3.1 Techdow (Hepalink) Details
    • 2.3.2 Techdow (Hepalink) Major Business
    • 2.3.3 Techdow (Hepalink) Enoxaparin Sodium Product and Services
    • 2.3.4 Techdow (Hepalink) Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Techdow (Hepalink) Recent Developments/Updates
  • 2.4 Fresenius Kabi
    • 2.4.1 Fresenius Kabi Details
    • 2.4.2 Fresenius Kabi Major Business
    • 2.4.3 Fresenius Kabi Enoxaparin Sodium Product and Services
    • 2.4.4 Fresenius Kabi Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Fresenius Kabi Recent Developments/Updates
  • 2.5 Rovi
    • 2.5.1 Rovi Details
    • 2.5.2 Rovi Major Business
    • 2.5.3 Rovi Enoxaparin Sodium Product and Services
    • 2.5.4 Rovi Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Rovi Recent Developments/Updates
  • 2.6 Amphastar
    • 2.6.1 Amphastar Details
    • 2.6.2 Amphastar Major Business
    • 2.6.3 Amphastar Enoxaparin Sodium Product and Services
    • 2.6.4 Amphastar Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Amphastar Recent Developments/Updates
  • 2.7 Nanjing King-friend
    • 2.7.1 Nanjing King-friend Details
    • 2.7.2 Nanjing King-friend Major Business
    • 2.7.3 Nanjing King-friend Enoxaparin Sodium Product and Services
    • 2.7.4 Nanjing King-friend Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Nanjing King-friend Recent Developments/Updates
  • 2.8 Sandoz
    • 2.8.1 Sandoz Details
    • 2.8.2 Sandoz Major Business
    • 2.8.3 Sandoz Enoxaparin Sodium Product and Services
    • 2.8.4 Sandoz Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Sandoz Recent Developments/Updates
  • 2.9 Apotex
    • 2.9.1 Apotex Details
    • 2.9.2 Apotex Major Business
    • 2.9.3 Apotex Enoxaparin Sodium Product and Services
    • 2.9.4 Apotex Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Apotex Recent Developments/Updates
  • 2.10 Hangzhou Jiuyuan Gene Engineering
    • 2.10.1 Hangzhou Jiuyuan Gene Engineering Details
    • 2.10.2 Hangzhou Jiuyuan Gene Engineering Major Business
    • 2.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product and Services
    • 2.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments/Updates
  • 2.11 Cipla
    • 2.11.1 Cipla Details
    • 2.11.2 Cipla Major Business
    • 2.11.3 Cipla Enoxaparin Sodium Product and Services
    • 2.11.4 Cipla Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Cipla Recent Developments/Updates
  • 2.12 Taj Pharma
    • 2.12.1 Taj Pharma Details
    • 2.12.2 Taj Pharma Major Business
    • 2.12.3 Taj Pharma Enoxaparin Sodium Product and Services
    • 2.12.4 Taj Pharma Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Taj Pharma Recent Developments/Updates
  • 2.13 Chengdu Baiyu Pharmaceutical
    • 2.13.1 Chengdu Baiyu Pharmaceutical Details
    • 2.13.2 Chengdu Baiyu Pharmaceutical Major Business
    • 2.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product and Services
    • 2.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
  • 2.14 Suzhou Erye Pharmaceutical
    • 2.14.1 Suzhou Erye Pharmaceutical Details
    • 2.14.2 Suzhou Erye Pharmaceutical Major Business
    • 2.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product and Services
    • 2.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Suzhou Erye Pharmaceutical Recent Developments/Updates
  • 2.15 Changzhou Qianhong Bio-pharma
    • 2.15.1 Changzhou Qianhong Bio-pharma Details
    • 2.15.2 Changzhou Qianhong Bio-pharma Major Business
    • 2.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product and Services
    • 2.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
  • 2.16 Hebei Changshan Biochemical Pharmaceutical
    • 2.16.1 Hebei Changshan Biochemical Pharmaceutical Details
    • 2.16.2 Hebei Changshan Biochemical Pharmaceutical Major Business
    • 2.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product and Services
    • 2.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
  • 2.17 Beijing SL Pharmaceutical
    • 2.17.1 Beijing SL Pharmaceutical Details
    • 2.17.2 Beijing SL Pharmaceutical Major Business
    • 2.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Product and Services
    • 2.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Beijing SL Pharmaceutical Recent Developments/Updates
  • 2.18 Huadong Medicine
    • 2.18.1 Huadong Medicine Details
    • 2.18.2 Huadong Medicine Major Business
    • 2.18.3 Huadong Medicine Enoxaparin Sodium Product and Services
    • 2.18.4 Huadong Medicine Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Huadong Medicine Recent Developments/Updates
  • 2.19 Bharat Serums
    • 2.19.1 Bharat Serums Details
    • 2.19.2 Bharat Serums Major Business
    • 2.19.3 Bharat Serums Enoxaparin Sodium Product and Services
    • 2.19.4 Bharat Serums Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Bharat Serums Recent Developments/Updates
  • 2.20 INTAS
    • 2.20.1 INTAS Details
    • 2.20.2 INTAS Major Business
    • 2.20.3 INTAS Enoxaparin Sodium Product and Services
    • 2.20.4 INTAS Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 INTAS Recent Developments/Updates
  • 2.21 LUPIN
    • 2.21.1 LUPIN Details
    • 2.21.2 LUPIN Major Business
    • 2.21.3 LUPIN Enoxaparin Sodium Product and Services
    • 2.21.4 LUPIN Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 LUPIN Recent Developments/Updates
  • 2.22 Troikaa Pharmaceuticals
    • 2.22.1 Troikaa Pharmaceuticals Details
    • 2.22.2 Troikaa Pharmaceuticals Major Business
    • 2.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Product and Services
    • 2.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.22.5 Troikaa Pharmaceuticals Recent Developments/Updates
  • 2.23 Aristopharma
    • 2.23.1 Aristopharma Details
    • 2.23.2 Aristopharma Major Business
    • 2.23.3 Aristopharma Enoxaparin Sodium Product and Services
    • 2.23.4 Aristopharma Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.23.5 Aristopharma Recent Developments/Updates
  • 2.24 Fosun Pharma
    • 2.24.1 Fosun Pharma Details
    • 2.24.2 Fosun Pharma Major Business
    • 2.24.3 Fosun Pharma Enoxaparin Sodium Product and Services
    • 2.24.4 Fosun Pharma Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.24.5 Fosun Pharma Recent Developments/Updates
  • 2.25 SciencePharma
    • 2.25.1 SciencePharma Details
    • 2.25.2 SciencePharma Major Business
    • 2.25.3 SciencePharma Enoxaparin Sodium Product and Services
    • 2.25.4 SciencePharma Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.25.5 SciencePharma Recent Developments/Updates
  • 2.26 PISA
    • 2.26.1 PISA Details
    • 2.26.2 PISA Major Business
    • 2.26.3 PISA Enoxaparin Sodium Product and Services
    • 2.26.4 PISA Enoxaparin Sodium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.26.5 PISA Recent Developments/Updates

3 Competitive Environment: Enoxaparin Sodium by Manufacturer

  • 3.1 Global Enoxaparin Sodium Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Enoxaparin Sodium Revenue by Manufacturer (2018-2023)
  • 3.3 Global Enoxaparin Sodium Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Enoxaparin Sodium by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Enoxaparin Sodium Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Enoxaparin Sodium Manufacturer Market Share in 2022
  • 3.5 Enoxaparin Sodium Market: Overall Company Footprint Analysis
    • 3.5.1 Enoxaparin Sodium Market: Region Footprint
    • 3.5.2 Enoxaparin Sodium Market: Company Product Type Footprint
    • 3.5.3 Enoxaparin Sodium Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Enoxaparin Sodium Market Size by Region
    • 4.1.1 Global Enoxaparin Sodium Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Enoxaparin Sodium Consumption Value by Region (2018-2029)
    • 4.1.3 Global Enoxaparin Sodium Average Price by Region (2018-2029)
  • 4.2 North America Enoxaparin Sodium Consumption Value (2018-2029)
  • 4.3 Europe Enoxaparin Sodium Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Enoxaparin Sodium Consumption Value (2018-2029)
  • 4.5 South America Enoxaparin Sodium Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Enoxaparin Sodium Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Enoxaparin Sodium Sales Quantity by Type (2018-2029)
  • 5.2 Global Enoxaparin Sodium Consumption Value by Type (2018-2029)
  • 5.3 Global Enoxaparin Sodium Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Enoxaparin Sodium Sales Quantity by Application (2018-2029)
  • 6.2 Global Enoxaparin Sodium Consumption Value by Application (2018-2029)
  • 6.3 Global Enoxaparin Sodium Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Enoxaparin Sodium Sales Quantity by Type (2018-2029)
  • 7.2 North America Enoxaparin Sodium Sales Quantity by Application (2018-2029)
  • 7.3 North America Enoxaparin Sodium Market Size by Country
    • 7.3.1 North America Enoxaparin Sodium Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Enoxaparin Sodium Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Enoxaparin Sodium Sales Quantity by Type (2018-2029)
  • 8.2 Europe Enoxaparin Sodium Sales Quantity by Application (2018-2029)
  • 8.3 Europe Enoxaparin Sodium Market Size by Country
    • 8.3.1 Europe Enoxaparin Sodium Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Enoxaparin Sodium Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Enoxaparin Sodium Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Enoxaparin Sodium Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Enoxaparin Sodium Market Size by Region
    • 9.3.1 Asia-Pacific Enoxaparin Sodium Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Enoxaparin Sodium Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Enoxaparin Sodium Sales Quantity by Type (2018-2029)
  • 10.2 South America Enoxaparin Sodium Sales Quantity by Application (2018-2029)
  • 10.3 South America Enoxaparin Sodium Market Size by Country
    • 10.3.1 South America Enoxaparin Sodium Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Enoxaparin Sodium Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Enoxaparin Sodium Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Enoxaparin Sodium Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Enoxaparin Sodium Market Size by Country
    • 11.3.1 Middle East & Africa Enoxaparin Sodium Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Enoxaparin Sodium Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Enoxaparin Sodium Market Drivers
  • 12.2 Enoxaparin Sodium Market Restraints
  • 12.3 Enoxaparin Sodium Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Enoxaparin Sodium and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Enoxaparin Sodium
  • 13.3 Enoxaparin Sodium Production Process
  • 13.4 Enoxaparin Sodium Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Enoxaparin Sodium Typical Distributors
  • 14.3 Enoxaparin Sodium Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Enoxaparin Sodium. Industry analysis & Market Report on Enoxaparin Sodium is a syndicated market report, published as Global Enoxaparin Sodium Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Enoxaparin Sodium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,787.48
    		4,181.22
    		5,574.96
    		3,250.32
    		4,875.48
    		6,500.64
    		548,065.20
    		822,097.80
    		1,096,130.40
    		290,197.20
    		435,295.80
    		580,394.40
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo